VI
Vitrolife AB (publ)
VITR.ST · STO
91.10 kr -1.09% (-1.00 kr)
1M +1.15%
Market Cap 12.5B kr
P/E Ratio -
Div. Yield -
ROE 53.29%
Bulios Fair Price
61.88 kr
32.1% downside
Trenutna cena
91.1 kr
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VITR.ST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
70 /100
Cheap P/B 1.53x
P/FCF 20.35x
P/S 3.68x
Growth
15 /100
Declining FCF growth 12.72%
Book val. growth 22.16%
Rev. growth 2.08%
Profitability
74 /100
Strong Net margin 146.96%
Op. margin 19.50%
FCF margin 18.08%
Quality
17 /100
Poor ROE 53.29%
ROA 44.08%
Asset turnover 0.30x
Debt
69 /100
Low Current ratio 3.64x
Int. coverage -85.11x
Debt/Equity 0.20x
Stability
35 /100
Moderate Rev. volatility 6.66%
EPS volatility 687.91%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VITR.ST
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Bronwyn Brophy O'Connor
Employees
1,103
Headquarters
Gothenburg
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report